166 related articles for article (PubMed ID: 15664852)
1. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B.
Cunha RL; Urano ME; Chagas JR; Almeida PC; Bincoletto C; Tersariol IL; Comasseto JV
Bioorg Med Chem Lett; 2005 Feb; 15(3):755-60. PubMed ID: 15664852
[TBL] [Abstract][Full Text] [Related]
2. Octa-O-bis-(R,R)-Tartarate Ditellurane (SAS) - a novel bioactive organotellurium(IV) compound: synthesis, characterization, and protease inhibitory activity.
Yosef S; Brodsky M; Sredni B; Albeck A; Albeck M
ChemMedChem; 2007 Nov; 2(11):1601-6. PubMed ID: 17680580
[TBL] [Abstract][Full Text] [Related]
3. Irreversible inhibition of human cathepsins B, L, S and K by hypervalent tellurium compounds.
Cunha RL; Gouvêa IE; Feitosa GP; Alves MF; Brömme D; Comasseto JV; Tersariol IL; Juliano L
Biol Chem; 2009 Nov; 390(11):1205-12. PubMed ID: 19663682
[TBL] [Abstract][Full Text] [Related]
4. Rhenium inhibitors of cathepsin B (ReO(SYS)X (where Y = S, py; X = Cl, Br, SPhOMe-p)): Synthesis and mechanism of inhibition.
Mosi R; Baird IR; Cox J; Anastassov V; Cameron B; Skerlj RT; Fricker SP
J Med Chem; 2006 Aug; 49(17):5262-72. PubMed ID: 16913715
[TBL] [Abstract][Full Text] [Related]
5. Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity.
van Zutphen S; Kraus M; Driessen C; van der Marel GA; Overkleeft HS; Reedijk J
J Inorg Biochem; 2005 Jun; 99(6):1384-9. PubMed ID: 15869797
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium(IV) compound RT-04.
Abondanza TS; Oliveira CR; Barbosa CM; Pereira FE; Cunha RL; Caires AC; Comasseto JV; Queiroz ML; Valadares MC; Bincoletto C
Food Chem Toxicol; 2008 Jul; 46(7):2540-5. PubMed ID: 18495315
[TBL] [Abstract][Full Text] [Related]
7. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
[TBL] [Abstract][Full Text] [Related]
8. Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.
Miyamoto Y; Akaike T; Alam MS; Inoue K; Hamamoto T; Ikebe N; Yoshitake J; Okamoto T; Maeda H
Biochem Biophys Res Commun; 2000 Jan; 267(3):918-23. PubMed ID: 10673391
[TBL] [Abstract][Full Text] [Related]
9. Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasis.
Lim IT; Meroueh SO; Lee M; Heeg MJ; Mobashery S
J Am Chem Soc; 2004 Aug; 126(33):10271-7. PubMed ID: 15315439
[TBL] [Abstract][Full Text] [Related]
10. The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
Valente C; Moreira R; Guedes RC; Iley J; Jaffar M; Douglas KT
Bioorg Med Chem; 2007 Aug; 15(15):5340-50. PubMed ID: 17532221
[TBL] [Abstract][Full Text] [Related]
11. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
12. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lysosomal cysteine proteases by a series of Au(I) complexes: a detailed mechanistic investigation.
Gunatilleke SS; Barrios AM
J Med Chem; 2006 Jun; 49(13):3933-7. PubMed ID: 16789749
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity.
Zhu Y; Cameron BR; Mosi R; Anastassov V; Cox J; Qin L; Santucci Z; Metz M; Skerlj RT; Fricker SP
J Inorg Biochem; 2011 May; 105(5):754-62. PubMed ID: 21481817
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of cysteine proteases.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
[TBL] [Abstract][Full Text] [Related]
17. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
[TBL] [Abstract][Full Text] [Related]
18. Organotellurium compound toxicity in a promyelocytic cell line compared to non-tellurium-containing organic analog.
Sailer BL; Liles N; Dickerson S; Sumners S; Chasteen TG
Toxicol In Vitro; 2004 Aug; 18(4):475-82. PubMed ID: 15130605
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin B inhibitors: Further exploration of the nitroxoline core.
Sosič I; Mitrović A; Ćurić H; Knez D; Brodnik Žugelj H; Štefane B; Kos J; Gobec S
Bioorg Med Chem Lett; 2018 Apr; 28(7):1239-1247. PubMed ID: 29503024
[TBL] [Abstract][Full Text] [Related]
20. Poliovirus 3C proteinase inhibition by organotelluranes.
Gouvea IE; Santos JA; Burlandy FM; Tersariol IL; da Silva EE; Juliano MA; Juliano L; Cunha RL
Biol Chem; 2011 Apr; 392(6):587-91. PubMed ID: 21521074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
